[1]董松武,张静.急性ST 段抬高型心肌梗死患者冠状动脉无复流诊疗进展[J].国际心血管病杂志,2023,06:365-368.
点击复制
急性ST 段抬高型心肌梗死患者冠状动脉无复流诊疗进展(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2023年06期
- 页码:
- 365-368
- 栏目:
- 综述
- 出版日期:
- 2023-11-20
文章信息/Info
- Title:
- -
- Author(s):
- -
- 关键词:
- 急性ST 段抬高型心肌梗死; 经皮冠状动脉介入治疗; 无复流
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2023.06.008
- 文献标识码:
- -
- 摘要:
- 经皮冠状动脉介入治疗（PCI）是急性ST 段抬高型心肌梗死（STEMI）的有 效治疗手段。冠状动脉无复流导致心肌灌注不足，是急诊PCI 失败的主要原因。冠状动脉无 复流与微循环的功能及结构改变有关，该文介绍STEMI 患者冠状动脉无复流的病理生理机 制和诊疗进展。
- Abstract:
- -
参考文献/References
[1] Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for
the management of acute myocardial infarction in patients
presenting with ST-segment elevation: the task force for
the management of acute myocardial infarction in patients
presenting with ST-segment elevation of the European Society
of Cardiology (ESC)[J]. Eur Heart J, 2018, 39(2):119-177.
[2] Durante A, Laricchia A, Benedetti G, et al. Identification of
high-risk patients after ST-segment-elevation myocardial
infarction: comparison between angiographic and magnetic
resonance parameters[J]. Circ Cardiovasc Imaging, 2017,
10(6):e005841.
[3] Tasar O, Karabay AK, Oduncu V, et al. Predictors and
outcomes of no-reflow phenomenon in patients with acute STsegment
elevation myocardial infarction undergoing primary
percutaneous coronary intervention[J]. Coron Artery Dis,
2019, 30(4):270-276.
[4] Bessonov IS, Kuznetsov VA, Gorbatenko EA, et al. Influence
of total ischemic time on clinical outcomes in patients with
ST-segment elevation myocardial infarction[J]. Kardiologiia,
2021, 61(2):40-46.
[5] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员
会. ST段抬高型心肌梗死患者急诊PCI微循环保护策略中
国专家共识[J]. 中华心血管病杂志, 2022, 50(3):221-230.
[6] Kloner RA, King KS, Harrington MG. No-reflow phenomenon
in the heart and brain[J]. Am J Physiol Heart Circ Physiol,
2018, 315(3):H550-H562.
[7] He B, Ding S, Qiao ZQ, et al. Influence of microvascular
dysfunction on regional myocardial deformation post-acute
myocardial infarction: insights from a novel angiographic
index for assessing myocardial tissue-level reperfusion[J]. Int
J Cardiovasc Imaging, 2016, 32(5):711-719.
[8] Ko?uch M, Po?udniewski M, D?browski EJ, et al. Growth
differentiation factor 15 as a predictor of the no-reflow
phenomenon in patients with ST-segment elevation myocardial
infarction[J]. J Clin Med, 2022, 12(1):245.
[9] Vogelzang M, Vlaar PJ, Svilaas T, et al. Computer-assisted
myocardial blush quantification after percutaneous coronary
angioplasty for acute myocardial infarction: a substudy from
the TAPAS trial[J]. Eur Heart J, 2009, 30(5):594-599.
[10] Everaars H, de Waard GA, Driessen RS, et al. Doppler flow
velocity and thermodilution to assess coronary flow reserve:
a head-to-head comparison with
[15O]H2O PET[J]. JACC
Cardiovasc Interv, 2018, 11(20):2044-2054.
[11] Fahrni G, Wolfrum M, De Maria GL, et al. Index of
microcirculatory resistance at the time of primary percutaneous
coronary intervention predicts early cardiac complications:
insights from the OxAMI (Oxford study in acute myocardial
infarction) cohort[J]. J Am Heart Assoc, 2017, 6(11):e005409.
[12] De Maria GL, Scarsini R, Shanmuganathan M, et al.
Angiography-derived index of microcirculatory resistance
as a novel, pressure-wire-free tool to assess coronary
microcirculation in ST elevation myocardial infarction[J]. Int J
Cardiovasc Imaging, 2020, 36(8):1395-1406.
[13] Scarsini R, Shanmuganathan M, Kotronias RA, et al.
Angiography-derived index of microcirculatory resistance
(IMRangio) as a novel pressure-wire-free tool to assess
coronary microvascular dysfunction in acute coronary
syndromes and stable coronary artery disease[J]. Int J
Cardiovasc Imaging, 2021, 37(6):1801-1813.
[14] Tu SX, Ding DX, Chang YX, et al. Diagnostic accuracy of
quantitative flow ratio for assessment of coronary stenosis
significance from a single angiographic view: a novel method
based on bifurcation fractal law[J]. Catheter Cardiovasc Interv,
2021, 97 Suppl 2:1040-1047.
[15] Sheng XC, Qiao ZQ, Ge H, et al. Novel application of
quantitative flow ratio for predicting microvascular dysfunction
after ST-segment-elevation myocardial infarction[J]. Catheter
Cardiovasc Interv, 2020, 95Suppl 1:624-632.
[16] Spitaleri G, Brugaletta S, Scalone G, et al. Role of STsegment
resolution in patients with ST-segment elevation
myocardial infarction treated with primary percutaneous
coronary intervention (from the 5-Year outcomes of the
EXAMINATION [evaluation of the Xience-V stent in
acute myocardial infarction] trial)[J]. Am J Cardiol, 2018,
121(9):1039-1045.
[17] Reindl M, Eitel I, Reinstadler SJ. Role of cardiac magnetic
resonance to improve risk prediction following acute STelevation
myocardial infarction[J]. J Clin Med, 2020,
9(4):1041.
[18] Lautam?ki R, Schuleri KH, Sasano T, et al. Integration of
infarct size, tissue perfusion, and metabolism by hybrid
cardiac positron emission tomography/computed tomography:
evaluation in a porcine model of myocardial infarction[J]. Circ
Cardiovasc Imaging, 2009, 2(4):299-305.
[19] Hausenloy DJ, Kharbanda RK, M?ller UK, et al. Effect of
remote ischaemic conditioning on clinical outcomes in patients
with acute myocardial infarction (CONDI-2/ERIC-PPCI):
a single-blind randomised controlled trial[J]. Lancet, 2019,
394(10207):1415-1424.
[20] Ma M, Wang L, Diao KY, et al. A randomized controlled
clinical trial of prolonged balloon inflation during stent
deployment strategy in primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction: a
pilot study[J]. BMC Cardiovasc Disord, 2022, 22(1):30.
[21] Jolly SS, Cairns JA, Yusuf S, et al. Randomized trial of
primary PCI with or without routine manual thrombectomy[J].
N Engl J Med, 2015, 372(15):1389-1398.
[22] Egred M, Bagnall A, Spyridopoulos I, et al. Effect of pressurecontrolled
intermittent coronary sinus occlusion (PiCSO) on
infarct size in anterior STEMI: PiCSO in ACS study[J]. Int J
Cardiol Heart Vasc, 2020, 28:100526.
[23] De Maria GL, Alkhalil M, Borlotti A, et al. Index of
microcirculatory resistance-guided therapy with pressurecontrolled
intermittent coronary sinus occlusion improves
coronary microvascular function and reduces infarct size in
patients with ST-elevation myocardial infarction: the Oxford
Acute Myocardial Infarction-Pressure-controlled Intermittent
Coronary Sinus Occlusion study (OxAMI-PICSO study)[J].
EuroIntervention, 2018, 14(3):e352-e359.
[24] Erlinge D, G?tberg M, Lang I, et al. Rapid endovascular
catheter core cooling combined with cold saline as an adjunct
to percutaneous coronary intervention for the treatment
of acute myocardial infarction. The CHILL-MI trial: a
randomized controlled study of the use of central venous
catheter core cooling combined with cold saline as an adjunct
to percutaneous coronary intervention for the treatment of
acute myocardial infarction[J].J Am Coll Cardiol, 2014,
63(18):1857-1865.
[25] El Farissi M, Keulards DCJ, van't Veer M, et al. Selective
intracoronary hypothermia in patients with ST-elevation
myocardial infarction. Rationale and design of the EURO-ICE
trial[J]. EuroIntervention, 2021, 16(17):1444-1446.
[26] Shibata N, Takagi K, Morishima I, et al. The impact of the
excimer laser on myocardial salvage in ST-elevation acute
myocardial infarction via nuclear scintigraphy[J]. Int J
Cardiovasc Imaging, 2020, 36(1):161-170.
[27] Qiao SG, Zhao WJ, Li HQ, et al. Necrostatin-1 analog DIMO
exerts cardioprotective effect against ischemia reperfusion
injury by suppressing necroptosis via autophagic pathway in
rats[J]. Pharmacology, 2021, 106(3/4):189-201.
[28] Ali Pour P, Kenney MC, Kheradvar A. Bioenergetics
consequences of mitochondrial transplantation in
cardiomyocytes[J]. J Am Heart Assoc, 2020, 9(7):e014501.
[29] Kaul S, Methner C, Cao ZP, et al. Mechanisms of the "noreflow"
phenomenon after acute myocardial infarction:
potential role of pericytes[J]. JACC Basic Transl Sci, 2022,
8(2):204-220.
备注/Memo
- 备注/Memo:
- 通信作者：张静， E-mail：bzyyzhangjing@163.com
常用功能
统计/Statistics
- 摘要浏览/Viewed5
- 全文下载/Downloads310
- 评论/Comments
